All of the active B12 group reporting showed reduction in severity of symptoms ranging from 31% to 70%, while breast and enlargement the placebo controls reported either no change or a worsening of symptoms. Wilcoxon-Rank herb and breast of .002 for the end-points enlargement of sneezing, nasal congestion herb and runny breast nose; and p = .005 for IgE reductions. In 1992, the above mentioned data from 1988 on were presented by Dr. enlargement O''Connor to the FDA. The FDA panel acknowledged the safety of the treatment. The herb panel seemed to be in breast agreement enlargement and herb that the statistics indicated a significant reduction in IgE and that a quantitative breast drop in symptoms enlargement was demonstrated. In 1992, Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance herb confirmed breast by oral challenge testing. The test was repeated after premedication with 1.5 mg enlargement of oral cyanocobalamin. herb In four of the breast five patients treated, bronchospasm enlargement and herb did not develop in the second metabisulfite breast challenge.6

With no further treatment, the 1996 ten-month enlargement follow-up data (n=92) from a high pollen herb period in Oregon, Washington and Idaho together showed a greater reduction in the active group (n=43) than the placebo group (n=49) on the primary endpoint, breast defined enlargement as a combination of symptom and rescue medication herb scores.8 Patients gave blood serum samples prior to the treatment in 1995 and one year later in 1996. They were immunoassayed for specific IgE antibodies using a chemi-luminescent technique. Statistician Bradley Rosebrook ran T-Tests comparing average baseline IgE levels breast to one-year. For the seasonal allergens reported, the active group (n=27) had on average a greater reduction in IgE than the placebo enlargement group (n=34) for 13 out herb of 16 allergens.8

©2003 www.natural-breasts-enhancement.com All rights reserved.